BOSTON & GENEVA--(EON: Enhanced Online News)--PHT Clinical Science and Consulting is experiencing strong growth and expanding its service offerings as more pharmaceutical sponsors and CROs leverage PHT Corporation’s clinical science advice and best practices gained from 650+ eClinical studies.
“We’re driven to help pharmaceutical researchers and clinicians improve clinical research. Our team provides scientific evidence to strengthen patient-reported outcome data and improve the achievement of PRO labeling claims.”
PHT is the leading provider of innovative technology systems used to collect patient-driven eData for clinical research. Patient-driven eData encompasses all electronic clinical outcome assessments (eCOA) including patient reported outcomes (PRO), clinician reported (ClinRO) and observer or caregiver reported outcomes (ObsRO).
PHT Clinical Science and Consulting helps sponsors implement optimal eCOA trial design strategies that expedite the elucidation of drug safety and efficacy and help ensure the success of drug development programs. Watch this video and learn more about the PHT Clinical Science and Consulting Team http://bit.ly/consultingservicesteam
Increasingly, trial sponsors are turning to PHT to fulfill their needs related to the design, patient testing and implementation of PRO and eCOA instruments.
PHT President and CEO Philip Lee said, “Customers have been asking PHT for more scientific consultations in recent years as the market demand and regulatory interest in eCOA Systems has grown. By expanding our Consulting Services, PHT streamlines eCOA projects for clients and reduces project complexity and overall cost. “
The Team supplements and guides clients to strengthen outcomes for regulatory submissions. The most frequently requested services include:
- Instrument testing to provide validity evidence
- Concept elicitation interviewing
- Cognitive debriefing and usability testing
- Protocol review and program strategy
- Licensing agreements and quantitative patient testing
Core services now include weighting and scoring for assessments as a direct result of requests from pharmaceutical researchers for further evidence to justify instrument design. PHT scientists consult on eCOA design; gap analysis; dossier preparation; instrument selection and ePRO migration; and meta- and post-hoc analyses.
Susan M. Dallabrida PhD, Director of PHT Clinical Science and Consulting, said, “We’re driven to help pharmaceutical researchers and clinicians improve clinical research. Our team provides scientific evidence to strengthen patient-reported outcome data and improve the achievement of PRO labeling claims.”
PHT Clinical Science and Consulting Team also speak at industry events worldwide and conducts educational webinars. This year the Team has conducted webinars on Migraine, Diabetes and Oncology. The next webinar: ePRO Data for COPD Research takes place in November.
Learn how the PHT Clinical Science and Consulting Team can make your next clinical trial more efficient and cost-effective. Call 617-681-6375 or visit http://bit.ly/PHTConsulting
About PHT Corporation
PHT Corporation helps pharmaceutical companies and CROs conduct clinical trial programs with greater confidence, ease and accuracy. Proven PHT electronic clinical outcome assessment (eCOA) Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via StudyWorks™ online reporting portal, provides sponsors and clinicians with a real time window into how patients feel and function. PHT has helped trial sponsors collect patient-driven eData in 650+ global trials resulting in 16+ regulatory approvals. PHT Clinical Science and Consulting offers the scientific, regulatory, and technological expertise today’s eCOA market demands and patients deserve. Visit www.phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Twitter Google+ and YouTube.